文献速递关节外科创伤骨科

头孢他啶与氟康唑加入聚甲基丙烯酸甲酯骨水泥用于关节置换术的生物活性研究

Bioactivity of Ceftazidime and Fluconazole Included in Polymethyl Methacrylate Bone Cement for Use in Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-05-04

这项体外研究检测了头孢他啶与氟康唑按1:40和4:40比例(克抗生素/克骨水泥)加入骨水泥后的洗脱与生物活性。治疗比例下两药释放量分别较预防比例高453%和648%,生物活性模拟显示术后前3天释放量取决于微生物敏感性、拔管后明显增加,微生物学实验提示铜绿假单胞菌生物膜形成可能成为问题。

要点

  • 治疗比例下头孢他啶和氟康唑释放量分别较预防比例高453%和648%。
  • 术后前3天活性部位药物释放量取决于微生物敏感性,拔管后释放明显增加。
  • 使用头孢他啶时铜绿假单胞菌生物膜形成可能成为问题。

核心结论

  • 体外研究提示头孢他啶和氟康唑可加入聚甲基丙烯酸甲酯用于关节手术相关感染的预防/治疗,其疗效取决于引起感染的微生物的敏感性。

研究设计与样本

  • 体外研究,检测头孢他啶与氟康唑按1:40和4:40比例(克抗生素/克骨水泥)加入骨水泥圆柱体后的洗脱与生物活性。
  • 药物释放采用流通式溶出仪(SotaxCE7)测定;生物活性通过模拟1000例患者关节腔内药物浓度评估。
  • 抗菌性能通过菌落形成单位计数和抑菌环试验评价。

主要发现

  • 治疗比例下头孢他啶释放量较预防比例高453%,氟康唑释放量较预防比例高648%。
  • 生物活性模拟显示,术后前3天活性部位药物释放量取决于微生物敏感性,拔管后释放量明显增加。
  • 微生物学实验显示,无论治疗还是预防比例使用头孢他啶时,铜绿假单胞菌生物膜形成可能成为问题。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The microorganisms that most frequently cause prosthetic joint infection are methicillin-resistant Staphylococcus aureus and gram-negative aerobic bacillus. Studies have documented the efficacy of mixing antibiotics with polymethyl methacrylate, but that of antifungal drugs has not received much attention. The objective of this in vitro study was to characterize the elution profile and bioactivity of ceftazidime and fluconazole when incorporated into bone cement in proportions intended for prophylaxis and treatment of bone infections. METHODS: Antibiotic-loaded bone cement cylinders in a proportion of 1:40 and 4:40 (ratio of grams of antibiotic to grams of cement) were assayed. Drug delivery was investigated in a flow-through dissolution apparatus (SotaxCE7). To assess bioactivity, antibiotic concentrations were simulated in the joint space of 1000 patients. Antibacterial properties were evaluated by counting colony forming units and the inhibition-halo test. RESULTS: The ratio of released ceftazidime and fluconazole was 453% and 648%, respectively, higher when used for treatment proportions than prophylaxis proportions. A bioactivity simulation exercise showed that the efficacy of ceftazidime/fluconazole determined as the amount of drug is released at the active site in the first 3 days after surgery would depend on the sensitivity of the microorganism and would increase substantially after drain removal. The microbiology study showed that biofilm formation by Pseudomonas aeruginosa could be a problem when ceftazidime was used in treatment or prophylaxis proportions. CONCLUSION: Our in vitro findings suggest that ceftazidime and fluconazole can be added into polymethyl methacrylate for the prevention/treatment of infections associated to joint surgery. Their efficacy depends on the sensitivity of the microorganism causing the infection.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Martínez-Moreno J, Merino V, Nácher A, et al. Bioactivity of Ceftazidime and Fluconazole Included in Polymethyl Methacrylate Bone Cement for Use in Arthroplasty. J Arthroplasty. 2017. PMID: 28690040. doi:10.1016/j.arth.2017.04.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。